Your browser doesn't support javascript.
loading
Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical view.
Bencsikova, Beatrix; Bortlicek, Zbynek; Halamkova, Jana; Ostrizkova, Lenka; Kiss, Igor; Melichar, Bohuslav; Pavlik, Tomas; Dusek, Ladislav; Valik, Dalibor; Vyzula, Rostislav; Zdrazilova-Dubska, Lenka.
Afiliação
  • Bencsikova B; Department of Complex Oncology Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic. bencsikova@mou.cz.
  • Bortlicek Z; Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic. bencsikova@mou.cz.
  • Halamkova J; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic. bortlicek@iba.muni.cz.
  • Ostrizkova L; Department of Complex Oncology Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic. jana.halamkova@mou.cz.
  • Kiss I; Department of Internal Medicine and Hematooncology, University Hospital Brno, Brno, Czech Republic. lenka.ostrizkova@fnbrno.cz.
  • Melichar B; Department of Complex Oncology Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic. kiss@mou.cz.
  • Pavlik T; Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic. kiss@mou.cz.
  • Dusek L; Department of Oncology, Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic. bohuslav.melichar@fnol.cz.
  • Valik D; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic. pavlik@iba.muni.cz.
  • Vyzula R; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic. dusek@iba.muni.cz.
  • Zdrazilova-Dubska L; Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic. valik@mou.cz.
BMC Gastroenterol ; 15: 37, 2015 Mar 24.
Article em En | MEDLINE | ID: mdl-25888291

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas / Proteínas ras / Bevacizumab / Neoplasias Hepáticas / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged80 Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas / Proteínas ras / Bevacizumab / Neoplasias Hepáticas / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged80 Idioma: En Ano de publicação: 2015 Tipo de documento: Article